Screening for lysosomal diseases in a selected pediatric population: the case of Gaucher disease and acid sphingomyelinase deficiency

Abstract Background GD and ASMD are lysosomal storage disorders that enter into differential diagnosis due to the possible overlap in their clinical manifestations. The availability of safe and effective enzymatic therapies has recently led many investigators to develop and validate new screening to...

Full description

Bibliographic Details
Main Authors: Maja Di Rocco, Carlo Dionisi Vici, Alberto Burlina, Francesco Venturelli, Agata Fiumara, Simona Fecarotta, Maria Alice Donati, Marco Spada, Daniela Concolino, Andrea Pession
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Online Access:https://doi.org/10.1186/s13023-023-02797-0
_version_ 1797773962335223808
author Maja Di Rocco
Carlo Dionisi Vici
Alberto Burlina
Francesco Venturelli
Agata Fiumara
Simona Fecarotta
Maria Alice Donati
Marco Spada
Daniela Concolino
Andrea Pession
author_facet Maja Di Rocco
Carlo Dionisi Vici
Alberto Burlina
Francesco Venturelli
Agata Fiumara
Simona Fecarotta
Maria Alice Donati
Marco Spada
Daniela Concolino
Andrea Pession
author_sort Maja Di Rocco
collection DOAJ
description Abstract Background GD and ASMD are lysosomal storage disorders that enter into differential diagnosis due to the possible overlap in their clinical manifestations. The availability of safe and effective enzymatic therapies has recently led many investigators to develop and validate new screening tools, such as algorithms, for the diagnosis of LSDs where the lack of disease awareness or failure to implement newborn screening results in a delayed diagnosis. Results the proposed algorithm allows for the clinical and biochemical differentiation between GD and ASMD. It is based on enzyme activity assessed on dried blood spots by multiplexed tandem mass spectrometry (MS/MS) coupled to specific biomarkers as second-tier analysis. Conclusions we believe that this method will provide a simple, convenient and sensitive tool for the screening of a selected population that can be used by pediatricians and other specialists (such as pediatric hematologists and pediatric hepatologists) often engaged in diagnosing these disorders.
first_indexed 2024-03-12T22:13:48Z
format Article
id doaj.art-8945f64473ae4b1884493f16f820f68a
institution Directory Open Access Journal
issn 1750-1172
language English
last_indexed 2024-03-12T22:13:48Z
publishDate 2023-07-01
publisher BMC
record_format Article
series Orphanet Journal of Rare Diseases
spelling doaj.art-8945f64473ae4b1884493f16f820f68a2023-07-23T11:26:26ZengBMCOrphanet Journal of Rare Diseases1750-11722023-07-011811610.1186/s13023-023-02797-0Screening for lysosomal diseases in a selected pediatric population: the case of Gaucher disease and acid sphingomyelinase deficiencyMaja Di Rocco0Carlo Dionisi Vici1Alberto Burlina2Francesco Venturelli3Agata Fiumara4Simona Fecarotta5Maria Alice Donati6Marco Spada7Daniela Concolino8Andrea Pession9Department of Pediatrics, Unit of Rare Diseases IRCCS Istituto Giannina GasliniBambino Gesù Children’HospitalDivision of Inherited Metabolic Diseases, Department of Diagnostic Services, University HospitalPediatric Unit, Istituti di Ricovero e Cura a Carattere Scientifico Azienda Ospedaliero- Universitaria di Bologna, University of BolognaReferral Center for Inherited Metabolic Disorders, Pediatric Clinical, University-Hospital “Gaspare Rodolico - San Marco”Federico II UniversityMetabolic and Neuromuscular Unit, Meyer HospitalDepartment of Pediatrics, University of TorinoDepartment of Science of Health, Pediatric Unit, Magna Graecia University of CatanzaroPediatric Unit, Istituti di Ricovero e Cura a Carattere Scientifico Azienda Ospedaliero- Universitaria di Bologna, University of BolognaAbstract Background GD and ASMD are lysosomal storage disorders that enter into differential diagnosis due to the possible overlap in their clinical manifestations. The availability of safe and effective enzymatic therapies has recently led many investigators to develop and validate new screening tools, such as algorithms, for the diagnosis of LSDs where the lack of disease awareness or failure to implement newborn screening results in a delayed diagnosis. Results the proposed algorithm allows for the clinical and biochemical differentiation between GD and ASMD. It is based on enzyme activity assessed on dried blood spots by multiplexed tandem mass spectrometry (MS/MS) coupled to specific biomarkers as second-tier analysis. Conclusions we believe that this method will provide a simple, convenient and sensitive tool for the screening of a selected population that can be used by pediatricians and other specialists (such as pediatric hematologists and pediatric hepatologists) often engaged in diagnosing these disorders.https://doi.org/10.1186/s13023-023-02797-0Selected population screeningLysosomal Storage DiseasesGaucher DiseaseAcid Sphingomyelinase DeficiencySplenomegaly
spellingShingle Maja Di Rocco
Carlo Dionisi Vici
Alberto Burlina
Francesco Venturelli
Agata Fiumara
Simona Fecarotta
Maria Alice Donati
Marco Spada
Daniela Concolino
Andrea Pession
Screening for lysosomal diseases in a selected pediatric population: the case of Gaucher disease and acid sphingomyelinase deficiency
Orphanet Journal of Rare Diseases
Selected population screening
Lysosomal Storage Diseases
Gaucher Disease
Acid Sphingomyelinase Deficiency
Splenomegaly
title Screening for lysosomal diseases in a selected pediatric population: the case of Gaucher disease and acid sphingomyelinase deficiency
title_full Screening for lysosomal diseases in a selected pediatric population: the case of Gaucher disease and acid sphingomyelinase deficiency
title_fullStr Screening for lysosomal diseases in a selected pediatric population: the case of Gaucher disease and acid sphingomyelinase deficiency
title_full_unstemmed Screening for lysosomal diseases in a selected pediatric population: the case of Gaucher disease and acid sphingomyelinase deficiency
title_short Screening for lysosomal diseases in a selected pediatric population: the case of Gaucher disease and acid sphingomyelinase deficiency
title_sort screening for lysosomal diseases in a selected pediatric population the case of gaucher disease and acid sphingomyelinase deficiency
topic Selected population screening
Lysosomal Storage Diseases
Gaucher Disease
Acid Sphingomyelinase Deficiency
Splenomegaly
url https://doi.org/10.1186/s13023-023-02797-0
work_keys_str_mv AT majadirocco screeningforlysosomaldiseasesinaselectedpediatricpopulationthecaseofgaucherdiseaseandacidsphingomyelinasedeficiency
AT carlodionisivici screeningforlysosomaldiseasesinaselectedpediatricpopulationthecaseofgaucherdiseaseandacidsphingomyelinasedeficiency
AT albertoburlina screeningforlysosomaldiseasesinaselectedpediatricpopulationthecaseofgaucherdiseaseandacidsphingomyelinasedeficiency
AT francescoventurelli screeningforlysosomaldiseasesinaselectedpediatricpopulationthecaseofgaucherdiseaseandacidsphingomyelinasedeficiency
AT agatafiumara screeningforlysosomaldiseasesinaselectedpediatricpopulationthecaseofgaucherdiseaseandacidsphingomyelinasedeficiency
AT simonafecarotta screeningforlysosomaldiseasesinaselectedpediatricpopulationthecaseofgaucherdiseaseandacidsphingomyelinasedeficiency
AT mariaalicedonati screeningforlysosomaldiseasesinaselectedpediatricpopulationthecaseofgaucherdiseaseandacidsphingomyelinasedeficiency
AT marcospada screeningforlysosomaldiseasesinaselectedpediatricpopulationthecaseofgaucherdiseaseandacidsphingomyelinasedeficiency
AT danielaconcolino screeningforlysosomaldiseasesinaselectedpediatricpopulationthecaseofgaucherdiseaseandacidsphingomyelinasedeficiency
AT andreapession screeningforlysosomaldiseasesinaselectedpediatricpopulationthecaseofgaucherdiseaseandacidsphingomyelinasedeficiency